196 related articles for article (PubMed ID: 37748493)
1. Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study.
C-MORE/PHOSP-COVID Collaborative Group
Lancet Respir Med; 2023 Nov; 11(11):1003-1019. PubMed ID: 37748493
[TBL] [Abstract][Full Text] [Related]
2. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study.
Evans RA; McAuley H; Harrison EM; Shikotra A; Singapuri A; Sereno M; Elneima O; Docherty AB; Lone NI; Leavy OC; Daines L; Baillie JK; Brown JS; Chalder T; De Soyza A; Diar Bakerly N; Easom N; Geddes JR; Greening NJ; Hart N; Heaney LG; Heller S; Howard L; Hurst JR; Jacob J; Jenkins RG; Jolley C; Kerr S; Kon OM; Lewis K; Lord JM; McCann GP; Neubauer S; Openshaw PJM; Parekh D; Pfeffer P; Rahman NM; Raman B; Richardson M; Rowland M; Semple MG; Shah AM; Singh SJ; Sheikh A; Thomas D; Toshner M; Chalmers JD; Ho LP; Horsley A; Marks M; Poinasamy K; Wain LV; Brightling CE;
Lancet Respir Med; 2021 Nov; 9(11):1275-1287. PubMed ID: 34627560
[TBL] [Abstract][Full Text] [Related]
3. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study.
Dennis A; Wamil M; Alberts J; Oben J; Cuthbertson DJ; Wootton D; Crooks M; Gabbay M; Brady M; Hishmeh L; Attree E; Heightman M; Banerjee R; Banerjee A;
BMJ Open; 2021 Mar; 11(3):e048391. PubMed ID: 33785495
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study.
PHOSP-COVID Collaborative Group
Lancet Respir Med; 2022 Aug; 10(8):761-775. PubMed ID: 35472304
[TBL] [Abstract][Full Text] [Related]
5. Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study.
Jackson C; Stewart ID; Plekhanova T; Cunningham PS; Hazel AL; Al-Sheklly B; Aul R; Bolton CE; Chalder T; Chalmers JD; Chaudhuri N; Docherty AB; Donaldson G; Edwardson CL; Elneima O; Greening NJ; Hanley NA; Harris VC; Harrison EM; Ho LP; Houchen-Wolloff L; Howard LS; Jolley CJ; Jones MG; Leavy OC; Lewis KE; Lone NI; Marks M; McAuley HJC; McNarry MA; Patel BV; Piper-Hanley K; Poinasamy K; Raman B; Richardson M; Rivera-Ortega P; Rowland-Jones SL; Rowlands AV; Saunders RM; Scott JT; Sereno M; Shah AM; Shikotra A; Singapuri A; Stanel SC; Thorpe M; Wootton DG; Yates T; Gisli Jenkins R; Singh SJ; Man WD; Brightling CE; Wain LV; Porter JC; Thompson AAR; Horsley A; Molyneaux PL; Evans RA; Jones SE; Rutter MK; Blaikley JF;
Lancet Respir Med; 2023 Aug; 11(8):673-684. PubMed ID: 37072018
[TBL] [Abstract][Full Text] [Related]
6. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
Antonelli M; Penfold RS; Merino J; Sudre CH; Molteni E; Berry S; Canas LS; Graham MS; Klaser K; Modat M; Murray B; Kerfoot E; Chen L; Deng J; Österdahl MF; Cheetham NJ; Drew DA; Nguyen LH; Pujol JC; Hu C; Selvachandran S; Polidori L; May A; Wolf J; Chan AT; Hammers A; Duncan EL; Spector TD; Ourselin S; Steves CJ
Lancet Infect Dis; 2022 Jan; 22(1):43-55. PubMed ID: 34480857
[TBL] [Abstract][Full Text] [Related]
7. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study.
Pinato DJ; Tabernero J; Bower M; Scotti L; Patel M; Colomba E; Dolly S; Loizidou A; Chester J; Mukherjee U; Zambelli A; Dalla Pria A; Aguilar-Company J; Ottaviani D; Chowdhury A; Merry E; Salazar R; Bertuzzi A; Brunet J; Lambertini M; Tagliamento M; Pous A; Sita-Lumsden A; Srikandarajah K; Colomba J; Pommeret F; Seguí E; Generali D; Grisanti S; Pedrazzoli P; Rizzo G; Libertini M; Moss C; Evans JS; Russell B; Harbeck N; Vincenzi B; Biello F; Bertulli R; Liñan R; Rossi S; Carmona-García MC; Tondini C; Fox L; Baggi A; Fotia V; Parisi A; Porzio G; Saponara M; Cruz CA; García-Illescas D; Felip E; Roqué Lloveras A; Sharkey R; Roldán E; Reyes R; Earnshaw I; Ferrante D; Marco-Hernández J; Ruiz-Camps I; Gaidano G; Patriarca A; Bruna R; Sureda A; Martinez-Vila C; Sanchez de Torre A; Cantini L; Filetti M; Rimassa L; Chiudinelli L; Franchi M; Krengli M; Santoro A; Prat A; Van Hemelrijck M; Diamantis N; Newsom-Davis T; Gennari A; Cortellini A;
Lancet Oncol; 2021 Dec; 22(12):1669-1680. PubMed ID: 34741822
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study.
Drake TM; Riad AM; Fairfield CJ; Egan C; Knight SR; Pius R; Hardwick HE; Norman L; Shaw CA; McLean KA; Thompson AAR; Ho A; Swann OV; Sullivan M; Soares F; Holden KA; Merson L; Plotkin D; Sigfrid L; de Silva TI; Girvan M; Jackson C; Russell CD; Dunning J; Solomon T; Carson G; Olliaro P; Nguyen-Van-Tam JS; Turtle L; Docherty AB; Openshaw PJ; Baillie JK; Harrison EM; Semple MG;
Lancet; 2021 Jul; 398(10296):223-237. PubMed ID: 34274064
[TBL] [Abstract][Full Text] [Related]
10. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.
Huang L; Li X; Gu X; Zhang H; Ren L; Guo L; Liu M; Wang Y; Cui D; Wang Y; Zhang X; Shang L; Zhong J; Wang X; Wang J; Cao B
Lancet Respir Med; 2022 Sep; 10(9):863-876. PubMed ID: 35568052
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in South Africa: a prospective cohort study.
Dryden M; Mudara C; Vika C; Blumberg L; Mayet N; Cohen C; Tempia S; Parker A; Nel J; Perumal R; Groome MJ; Conradie F; Ndjeka N; Sigfrid L; Merson L; Jassat W
Lancet Glob Health; 2022 Sep; 10(9):e1247-e1256. PubMed ID: 35961348
[TBL] [Abstract][Full Text] [Related]
13. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study.
Pinato DJ; Aguilar-Company J; Ferrante D; Hanbury G; Bower M; Salazar R; Mirallas O; Sureda A; Plaja A; Cucurull M; Mesia R; Townsend S; Jackson A; Dalla Pria A; Newsom-Davis T; Handford J; Sita-Lumsden A; Apthorp E; Vincenzi B; Bertuzzi A; Brunet J; Lambertini M; Maluquer C; Pedrazzoli P; Biello F; Sinclair A; Bawany S; Khalique S; Rossi S; Rogers L; Murphy C; Belessiotis K; Carmona-García MC; Sharkey R; García-Illescas D; Rizzo G; Perachino M; Saoudi-Gonzalez N; Doonga K; Fox L; Roldán E; Gaidano G; Ruiz-Camps I; Bruna R; Patriarca A; Martinez-Vila C; Cantini L; Zambelli A; Giusti R; Mazzoni F; Caliman E; Santoro A; Grosso F; Parisi A; Queirolo P; Aujayeb A; Rimassa L; Prat A; Tucci M; Libertini M; Grisanti S; Mukherjee U; Diamantis N; Fusco V; Generali D; Provenzano S; Gennari A; Tabernero J; Cortellini A;
Lancet Oncol; 2022 Jul; 23(7):865-875. PubMed ID: 35660139
[TBL] [Abstract][Full Text] [Related]
15. 3-year outcomes of discharged survivors of COVID-19 following the SARS-CoV-2 omicron (B.1.1.529) wave in 2022 in China: a longitudinal cohort study.
Zhang H; Huang C; Gu X; Wang Y; Li X; Liu M; Wang Q; Xu J; Wang Y; Dai H; Zhang D; Cao B
Lancet Respir Med; 2024 Jan; 12(1):55-66. PubMed ID: 38000376
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study.
Antonelli M; Penfold RS; Canas LDS; Sudre C; Rjoob K; Murray B; Molteni E; Kerfoot E; Cheetham N; Pujol JC; Polidori L; May A; Wolf J; Modat M; Spector T; Hammers A; Ourselin S; Steves C
J Infect; 2023 Dec; 87(6):506-515. PubMed ID: 37777159
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study.
Swann OV; Holden KA; Turtle L; Pollock L; Fairfield CJ; Drake TM; Seth S; Egan C; Hardwick HE; Halpin S; Girvan M; Donohue C; Pritchard M; Patel LB; Ladhani S; Sigfrid L; Sinha IP; Olliaro PL; Nguyen-Van-Tam JS; Horby PW; Merson L; Carson G; Dunning J; Openshaw PJM; Baillie JK; Harrison EM; Docherty AB; Semple MG;
BMJ; 2020 Aug; 370():m3249. PubMed ID: 32960186
[TBL] [Abstract][Full Text] [Related]
18. Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial.
Butler CC; Yu LM; Dorward J; Gbinigie O; Hayward G; Saville BR; Van Hecke O; Berry N; Detry MA; Saunders C; Fitzgerald M; Harris V; Djukanovic R; Gadola S; Kirkpatrick J; de Lusignan S; Ogburn E; Evans PH; Thomas NPB; Patel MG; Hobbs FDR;
Lancet Respir Med; 2021 Sep; 9(9):1010-1020. PubMed ID: 34329624
[TBL] [Abstract][Full Text] [Related]
19. Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK.
Docherty AB; Mulholland RH; Lone NI; Cheyne CP; De Angelis D; Diaz-Ordaz K; Donegan C; Drake TM; Dunning J; Funk S; García-Fiñana M; Girvan M; Hardwick HE; Harrison J; Ho A; Hughes DM; Keogh RH; Kirwan PD; Leeming G; Nguyen Van-Tam JS; Pius R; Russell CD; Spencer RG; Tom BD; Turtle L; Openshaw PJ; Baillie JK; Harrison EM; Semple MG;
Lancet Respir Med; 2021 Jul; 9(7):773-785. PubMed ID: 34000238
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study.
Agrawal U; Katikireddi SV; McCowan C; Mulholland RH; Azcoaga-Lorenzo A; Amele S; Fagbamigbe AF; Vasileiou E; Grange Z; Shi T; Kerr S; Moore E; Murray JLK; Shah SA; Ritchie L; O'Reilly D; Stock SJ; Beggs J; Chuter A; Torabi F; Akbari A; Bedston S; McMenamin J; Wood R; Tang RSM; de Lusignan S; Hobbs FDR; Woolhouse M; Simpson CR; Robertson C; Sheikh A
Lancet Respir Med; 2021 Dec; 9(12):1439-1449. PubMed ID: 34599903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
